HSBC Holdings’s BioLife Solutions BLFS Stock Holding History

HSBC Holdings’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Sell	39,261 -6,315	-14%	-$148K	﹤0.01%	1893
2026 Q1	$874K	Buy	+45,576	New	+$1.01M	﹤0.01%	1943

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HSBC Holdings's BLFS Position: Q2 2026 in Review

HSBC Holdings reduced its BioLife Solutions (BLFS) stake by 14% in Q2 2026, selling an estimated $148K and leaving 39,261 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1893.

HSBC Holdings first reported a position in BLFS in Q1 2026 and has held it in 2 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

HSBC Holdings held 39,261 shares of BioLife Solutions worth $1.1M as of Q2 2026.
HSBC Holdings sold 6,315 BioLife Solutions shares in Q2 2026, an estimated $148K.
BioLife Solutions made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1893 holding.
HSBC Holdings first reported a position in BioLife Solutions in Q1 2026 and has held it in 2 quarters since.
216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.